Skip to main content
. 2014 Sep 15;35(10):1257–1264. doi: 10.1038/aps.2014.75

Figure 7.

Figure 7

NF-κB immunoreactivity in cardiomyocytes. The left panel shows the basal expression level of NF-κB in the control group. The NF-κB expression level was increased in the Dox group and was higher than in the control group. Treatment with liguzinediol at a dose of 10 mg/kg decreased the level of NF-κB expression (n=8).